Results 161 to 170 of about 66,519 (219)

Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine. [PDF]

Proteomes
Amrutkar M, Li Y, Finstadsveen AV, Verbeke CS, Gladhaug IP.   +4 more
europepmc   +1 more source

Microbubble Shell Stiffness Engineering Enhances Ultrasound Imaging, Drug Delivery, and Sonoporation. [PDF]

Adv Mater
Barmin RA, Moosavifar M, Rama E, Blöck J, Rix A, Petrovskii VS, Gumerov RA, Köhler J, Pohl M, Bastard C, Rütten S, Charlton L, Khiêm VN, Domenici F, Lisson T, Savina E, Zhang R, Baier J, Koletnik S, Koutsos V, Itskov M, Paradossi G, Schmitz G, Vermonden T, De Laporte L, Göstl R, Herrmann A, Potemkin II, Kiessling F, Lammers T, Pallares RM.   +30 more
europepmc   +1 more source

Amphiphilic Poly(N-vinylpyrrolidone) Biocomposites with Bortezomib and DR5-Selective TRAIL Variants: A Promising Approach to Pancreatic Cancer Treatment. [PDF]

Int J Mol Sci
Kukovyakina E, Isakova AA, Bagrov D, Gasparian M, Kuskov A, Yagolovich A.   +5 more
europepmc   +1 more source

CK2-mediated HDAC5 shuttling regulates DNA end resection through Ku70 deacetylation. [PDF]

Theranostics
Liang X, Zhao J, Li S, Wei R, Yu H, Zhang Q, Fu Q, Qin G, Zhao Y, Liu J, Liu Z, Peng T, Meng J, Gou S, Yin T, Wu H, Wang B, Zhou Y.   +17 more
europepmc   +1 more source

Revista paca

, 2019
openaire   +1 more source

Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug. [PDF]

Proc Natl Acad Sci U S A
Antonucci L, Watari K, Feng Y, Qi J, Zhu M, Wang T, Ng I, Vucic EA, Riahi I, Huang L, Hosseini M, Mose E, French R, Weitz J, Bar-Sagi D, Dawson DW, Sun B, Tiriac H, Xu J, Xu S, Lowy AM, Karin M.   +21 more
europepmc   +1 more source

F41, a Novel Fungal Indole-Diterpenoid, Overcomes Gemcitabine Resistance in Pancreatic Cancer by Inducing ER Stress. [PDF]

Int J Mol Sci
Gao Z, Liu L, Xu Y, Zhao C, Zhao X, Zhao T, Che Y, Zhao W.   +7 more
europepmc   +1 more source

A subplacenta da paca (Agouti paca, Linnaeus 1766) [PDF]

, 2015
openaire   +1 more source

Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers. [PDF]

Cell Rep Med
Frädrich J, Reyes CM, Hendel M, Brunner V, Toledo B, Manevski D, Sommer A, Häußler D, Beck D, Lucarelli D, Martínez de Villareal J, Halle L, Kfuri-Rubens R, Çifcibaşı K, Hirschberger A, Öllinger R, Knolle PA, Steiger K, Rad R, Theis FJ, Real FX, Bärthel S, Böttcher JP, Saur D, Demir IE, Krüger A.   +25 more
europepmc   +1 more source

EDC4 enhances multi-drug chemosensitivity in pancreatic cancer via GR50-based profiling. [PDF]

Cancer Cell Int
Qin C, Li T, Zhao B, Li Z, Zhao Y, Zhang X, Xie Y, Yan Y, Han J, Shao Q, Lin C, Wang W.   +11 more
europepmc   +1 more source